National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 1339146

Government Disclaimer on use of this data



Case Details

VAERS ID: 1339146 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-02
Onset:2021-03-26
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6790 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Cachexia, SARS-CoV-2 test negative
SMQs:, COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Dementia NOS; Hypertension; Pleural mesothelioma
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210222; Test Name: COVID-19 PCR test; Test Result: Negative ; Test Date: 20210309; Test Name: COVID-19 PCR test; Test Result: Negative
CDC Split Type: HUPFIZER INC2021560194

Write-up: cachexia; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB HU-OGYI-287221. This is a report received from the Regulatory Authority. Regulatory authority report number HU-OGYI-287221. An 81-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in arm left on 02Mar2021 (Batch/Lot Number: EJ6790) as 0.3 mL, single at the age of 81-year-old for COVID-19 immunisation. Medical history included ongoing hypertension, ongoing dementia, ongoing pleural mesothelioma. The patient''s concomitant medications were not reported. The patient was under in-patient care at the time of the vaccination. The hospitalization started on 14Dec2020. The patient experienced cachexia on 26Mar2021. The patient''s hospitalization was prolonged as a result of cachexia. The patient underwent lab tests and procedures which included Sars-cov-2 test: negative on 22Feb2021 and on 09Mar2021. The patient died on 14Apr2021 (also reported as 24 days after Comirnaty vaccination). An autopsy was not performed. According to the patient''s death certificate, the direct cause of death was cachexia, indirect causes were pleural mesothelioma and dementia NOS. The outcome of events was fatal. In the reporter physician''s opinion, the patient''s death was related to his underlying diseases. Reporter Comment: The 81- year-old patient died 24 days after Comirnaty vaccination. The cause of death was cachexia. The causal relationship between the reported death and the vaccine is considered unlikely. The case is serious due to fatal outcome. No follow-up attempts possible. No further information expected.; Reporter''s Comments: The 81- year-old patient died 24 days after Comirnaty vaccination. The cause of death was cachexia. The causal relationship between the reported death and the vaccine is considered unlikely. The case is serious due to fatal outcome.; Reported Cause(s) of Death: cachexia


New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=1339146


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166